Page results
-
This page provides information about the Palliative care and symptom control team
-
A surgical operation normally carried out to correct a blocked nasal passage may help patients who lost their sense of smell after contracting a COVID-19 infection, according to new research from UCLH.
-
This page has been written for patients who wish to find out more about a new procedure for epilepsy that does not involve removing parts of brain, known as EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy)
-
With all eyes on Paris for this summer’s Olympic Games, we look at how UCLH’s Institute of Sport, Health and Exercise (ISEH) has supported one of Britian’s Olympic hopefuls, and the care it provides for all kinds of sportspeople, from professionals to weekend warriors.
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
This page has been written for patients at Eastman Dental Hospital who are undergoing intravenous sedation.
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
File results
-
FOI/2023/0069 - Operations waits for under-18s
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0099 - Number of autoclaves used at Trust